Top U.S. health agency makes $25,000 buyout offer to most of its employees
Most of the 80,000 federal workers responsible for researching diseases, inspecting food and administering Medicare and ...
PTC Therapeutics: Upside In Rare Disease Innovation
PTC Therapeutics could boost revenue with vatiquinone for Friedreich's ataxia. Find out why PTCT stock is poised for growth ...
Managed Healthcare Executive14h
For Opzelura, Positive Results from One Trial, Less So From Another | AAD 2025
The ruxolitinib cream met its primary end point as a treatment for prurigo nodularis in one phase 3 trial but fell short in ...
Hays Post17h
Trump nominee to head up FDA made no commitments on abortion pill access
WASHINGTON — President Donald Trump’s nominee to lead the Food and Drug Administration refused to commit to keeping access to ...
Managed Healthcare Executive21h
Analysis Finds Opzelura Not Associated with Cancer or Cardiovascular Events
In this analysis presented at the American Academy of Dermatology annual meeting, serious adverse events were low, unrelated ...
Ozempic vs Metformin For Weight Loss: Weighing the Pros & Cons of Each
The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...
Anchorage Daily News23h
Marty Makary, often wrong as pandemic critic, is poised to lead the FDA he railed against
Should Marty Makary take the reins at the FDA, transitioning from gadfly to the head of an agency that regulates a fifth of ...